Stephen Brozak
Stock Analyst at WBB Securities
(2.99)
# 1,468
Out of 4,711 analysts
9
Total ratings
100%
Success rate
31.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Brozak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Maintains: Strong Buy | $40 → $45 | $23.22 | +93.80% | 6 | Dec 5, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Downgrades: Hold | $31 | $15.48 | +100.26% | 2 | Jun 9, 2020 | |
| PATH UiPath | Upgrades: Strong Buy | n/a | $13.25 | - | 1 | Jan 22, 2013 |
Cidara Therapeutics
Dec 5, 2024
Maintains: Strong Buy
Price Target: $40 → $45
Current: $23.22
Upside: +93.80%
Arcturus Therapeutics Holdings
Jun 9, 2020
Downgrades: Hold
Price Target: $31
Current: $15.48
Upside: +100.26%
UiPath
Jan 22, 2013
Upgrades: Strong Buy
Price Target: n/a
Current: $13.25
Upside: -